P&G is looking for new approaches and technologies that can help them to address key business challenges/opportunities.
Startups working on smarter exploration, lower-impact extraction, waste, water & materials recovery, and autonomy, robotics & digital infrastructure are invited to apply by February 2026. The program takes place in Perth (Australia) and remote. Select startups will receive 4 months of operational support.
Epoch Garage + is accepting applications for its Fall 2025 batch. Startups aiming to work with the Taiwanese and Asian markets, and ranging from Seed to Series B, are encourage to apply. Sectors include: AI & Data Analysis, IoT & Smart Devices, Digital Health, CarTech, 5G Technology, Robotics, Smart Energy, E-Mobility. Apply by September 8, 2025, using the link provided in the description.
P&G is looking for new technology-enabled solutions, services and business models that incentivize and drive lasting behavior change.
P&G is open to investigating composable architecture if there is no solution to address this opportunity in its entity. P&G is not looking for Designs only (without the ability to implement).
MIT Startup Exchange is seeking several startups to participate in the ILP The New Retail Series on November 12, 2020 (11 AM to 12 noon).
MIT Startup Exchange is working with IHS Markit and the MIT Energy Initiative to feature MIT Startups as speakers at the CERAWeek® Agora Innovation program, 9 - 12 March 2020, in Houston.
P&G LATAM seeks emerging technology and solutions that can help them further optimize their retail marketing and understand performance and sales uplift.
The annual MIT Information & Communication Technologies (ICT) webinar series will feature four sessions by eight MIT faculty on the following topics: urban infrastructure, wireless communications, low power/edge computing and human-machine interactions. We're looking for 6-8 startups for this webinar series.
A leading pharmaceutical company in Amyotrophic Lateral Sclerosis (ALS) is interested in speaking with startups whose technology could contribute to very early diagnosis of the disease.